Fertility Issues
67
16
18
24
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
3 terminated out of 67 trials
88.9%
+2.3% vs benchmark
4%
3 trials in Phase 3/4
13%
3 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (67)
Impact of Gonadotoxic Therapies on Fertility
Health Promotion Model, Fertility Awareness, Preconception Knowledge and Attitude
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
Frame Support Study
Fertility After Uterine Artery Embolization
Towards Optimal Fertility, Fathering and Fatherhood studY
Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)
The Stanford Egg Freezing Study
Outcome Evaluation After Fertility Preservation
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
Rescue Progesterone Supplementation During Frozen Embryo Transfer
Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG)
A Novel Ovarian Reserve Monitoring Algorithm for Patients at Risk of Ovarian Injury From Gonadotoxic Therapy
Testicular Tissue Cryopreservation (TTC)
Intervening on Women's Health for Rural Young Cancer Survivors
Addressing Fertility Information Needs and Distress